Include: 10 videos + 10 audios, size: 1.27 GB
Target Audience: hematologists/oncologists, hospitalists, internal medicine physicians
Information:
A concentrated, practice-focused update spanning benign and malignant hematology. Expert-led, case-based lectures translate evolving evidence and guidelines into clear diagnostic and treatment strategies you can apply immediately in clinic, hospital, and infusion settings.
What You Will Learn
-
How to streamline workups for anemia, cytopenias, coagulopathies, and thrombophilias
-
Evidence-based management of VTE: anticoagulant selection, duration, peri-procedural strategies
-
Current standards for leukemia, lymphoma, and myeloma—including frontline, relapsed/refractory, and maintenance approaches
-
Transfusion medicine pearls: product selection, thresholds, complications, and stewardship
-
Practical updates on targeted agents, immunotherapies, and cellular therapies—and how to manage toxicities
-
Supportive care essentials: infection prophylaxis, tumor lysis, TLS/SOS/VOD, and survivorship considerations
Event Details
-
Format: Live lectures with case discussions, board-style Q&A, and practical take-home checklists
-
Designed for: Rapid implementation in community and academic settings
-
Materials: Slide handouts and concise summaries for quick reference
Who Should Attend
Hematologists/oncologists, hospitalists, internal medicine physicians, advanced practice providers, pharmacists, and fellows seeking a high-yield, clinically oriented hematology refresh.
Why Attend
-
Convert complex trials and guidelines into simple, usable algorithms
-
Update your approach to diagnostics, therapeutics, and toxicity management
-
Leave with pragmatic tools to improve quality, safety, and patient outcomes
Topics:
| Saturday, February 17, 2024 | ||
| TIME | TOPIC | PRESENTER |
| 07:00 AM – 08:00 AM | Breakfast | Visit Exhibit Hall | Exhibitors | Attendees |
| 08:00 AM – 08:15 AM | Welcome | Introduction to Program | Robert S. Siegel, MD Professor of Medicine, Associate Center Director for Education and Training, The George Washington University, GW Cancer Center |
| 08:15 AM – 09:00 AM | Myeloproliferative Neoplasms | Ayalew Tefferi, MD Barbara Woodward Lips Professor of Medicine, Mayo Clinic |
| 09:00 AM – 09:45 AM | Multiple Myeloma | Kenneth Anderson, MD Kraft Family Professor of Medicine Dana-Farber Cancer Institute, Harvard Medical School |
| 09:45 AM – 10:00 AM | Break | Visit Exhibit Hall | Exhibitors | Attendees |
| 10:00 AM – 10:45 AM | Disorders of Coagulation | Kenneth A. Bauer, MD Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center |
| 10:45 AM – 11:30 AM | Acute Myeloid Leukemia | Samah Nassereddine, MD Assistant Professor of Medicine, The George Washington University, GW Cancer Center |
| 11:30 AM – 12:15 PM | Bone Marrow Failure Syndromes, PNH, and MDS | Amy DeZern, MD, MHS Associate Professor The Johns Hopkins University School of Medicine |
| 12:15 PM – 01:15 PM | Lunch | Visit Exhibit Hall | Exhibitors | Attendees |
| 12:15 PM – 01:15 PM | Lunch Product Forum sponsored by Pfizer | Speaker- TBC |
| 01:15 PM – 02:00 PM | Chronic Lymphocytic Leukemia | Imad A. Tabbara, MD Chief, Division of Hematology/Oncology of DeCesaris Cancer Institute, Anne Arundel Medical Center, Clinical Professor of Medicine, The George Washington University |
| 02:00 PM – 02:45 PM | Lymphoma | Nina Delaney Wagner-Johnston, MD Director of Lymphoma Drug Development, The Sidney Kimmel Comprehensive Cancer Center, Professor of Oncology, The Johns Hopkins University School of Medicine |
| 02:45 PM – 03:30 PM | Cellular Therapies | Catherine Bollard, MBChB, MD, FRACP, FRCPA Professor of Pediatrics, Director, Center for Cancer and Immunology Research, Children’s National Hospital and The George Washington University |
| 03:30 PM – 03:35 PM | Closing Remarks | Adjournment | Robert S. Siegel, MD Professor of Medicine, Associate Center Director for Education and Training, The George Washington University, GW Cancer Center |
Related products
Uncategorized
Uncategorized
